Continuous glucose monitors (CGMs) play a major role in diabetes management, but not all CGM accuracy and testing standards are the same. In this episode, I sit down with John Pemberton of Glucose Never Lies to break down how CGMs are tested, and why FDA clearance and CE marking aren’t equivalent when it comes to insulin dosing safety. As diabetes technology moves toward automated insulin delivery, we explore the risks of relying on data that may not be rigorously validated. We also cover the key questions every person with diabetes should ask before trusting their CGM.

Learn about Omnipod 5 (today's sponsor)*

Learn about the Eversense 365 CGM

Join the Diabetech Newsletter

Follow Diabetech: Instagram | Tik Tok | YouTube | Facebook | Threads

Follow The Glucose Never Lies: Instagram | Youtube | LinkedIn

DISCLAIMER: This podcast is not medical advice and is for educational purposes only. Always consult with your doctor before making changes to your health care. 

*10-day trial eligibility may vary. Full terms and conditions apply. Visit omnipod.com/diabetech for clinical disclaimers, terms and important safety information. The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.